These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25211439)

  • 1. Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status.
    van Santen DK; van der Helm JJ; Grady BP; de Vos AS; Kretzschmar ME; Stolte IG; Prins M
    AIDS; 2014 Nov; 28(17):2589-99. PubMed ID: 25211439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013).
    Klein MB; Rollet-Kurhajec KC; Moodie EE; Yaphe S; Tyndall M; Walmsley S; Gill J; Martel-Laferriere V; Cooper C;
    AIDS; 2014 Aug; 28(13):1957-65. PubMed ID: 25259703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection.
    Hernando V; Perez-Cachafeiro S; Lewden C; Gonzalez J; Segura F; Oteo JA; Rubio R; Dalmau D; Moreno S; Amo JD;
    J Hepatol; 2012 Oct; 57(4):743-51. PubMed ID: 22709620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
    Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
    J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
    Walter SR; Thein HH; Amin J; Gidding HF; Ward K; Law MG; George J; Dore GJ
    J Hepatol; 2011 May; 54(5):879-86. PubMed ID: 21145812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015.
    van Santen DK; van der Helm JJ; Lindenburg K; Schim van der Loeff M; Prins M
    Int J Drug Policy; 2017 Sep; 47():95-101. PubMed ID: 28606392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
    Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
    AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
    Klein MB; Rollet KC; Saeed S; Cox J; Potter M; Cohen J; Conway B; Cooper C; Côté P; Gill J; Haase D; Haider S; Hull M; Moodie E; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S;
    HIV Med; 2013 Jan; 14(1):10-20. PubMed ID: 22639840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
    Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
    J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.
    Marcellin P; Pequignot F; Delarocque-Astagneau E; Zarski JP; Ganne N; Hillon P; Antona D; Bovet M; Mechain M; Asselah T; Desenclos JC; Jougla E
    J Hepatol; 2008 Feb; 48(2):200-7. PubMed ID: 18086507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
    Mena A; Meijide H; Rodríguez-Osorio I; Castro A; Poveda E
    HIV Med; 2017 Oct; 18(9):685-689. PubMed ID: 28230318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is killing people with hepatitis C virus infection?
    Grebely J; Dore GJ
    Semin Liver Dis; 2011 Nov; 31(4):331-9. PubMed ID: 22189973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
    de Vos AS; van der Helm JJ; Matser A; Prins M; Kretzschmar ME
    Addiction; 2013 Jun; 108(6):1070-81. PubMed ID: 23347124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extreme cause-specific mortality in a cohort of adult prisoners--1988 to 2002: a data-linkage study.
    Kariminia A; Butler T; Corben S; Levy M; Grant L; Kaldor J; Law M
    Int J Epidemiol; 2007 Apr; 36(2):310-6. PubMed ID: 17158524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
    Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
    Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study.
    Duberg AS; Törner A; Davidsdóttir L; Aleman S; Blaxhult A; Svensson A; Hultcrantz R; Bäck E; Ekdahl K
    J Viral Hepat; 2008 Jul; 15(7):538-50. PubMed ID: 18397223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up.
    Kronfli N; Bhatnagar SR; Hull MW; Moodie EEM; Cox J; Walmsley S; Gill J; Cooper C; Martel-Laferrière V; Pick N; Klein MB;
    AIDS; 2019 May; 33(6):1013-1022. PubMed ID: 30946155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study.
    Hayashi K; Milloy MJ; Wood E; Dong H; Montaner JS; Kerr T
    J Int AIDS Soc; 2014; 17(1):19296. PubMed ID: 25391765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
    Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.